rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1983-4-21
|
pubmed:abstractText |
A plasma membrane fraction prepared from human neutrophils had a fluorescence resembling that of a fluorescent flavoprotein, with emission maximum near 520nm and excitation maxima near 380 and 460nm. The fluorescence emission and excitation properties of Triton N-101-solubilized membrane fraction resembled those of FAD. FAD was present in the membranes at a concentration of 417pmol/mg of protein and cytochrome b(-245) at a concentration of 407pmol/mg of protein. In a 110-fold purified preparation of cytochrome b(-245) the ratio of FAD:cytochrome b was 1:1. Analytical gradient centrifugation of neutrophil homogenates shows a coincidence of two cytochrome b peaks and two peaks of fluorescence, corresponding with plasma membrane and specific granule fractions; most of the FAD was non-fluorescent and located in fractions lighter than the plasma membrane. Plasma membrane fractions prepared from neutrophils of patients suffering from the X-linked form of chronic granulomatous disease lacked cytochrome b and contained 194pmol of FAD/mg of protein; plasma membrane fractions prepared from neutrophils of patients with the autosomal recessive form of chronic granulomatous disease contained both cytochrome b(-245) and FAD in the normal range of concentrations in a ratio of 1:1. Phagocytic vesicles were prepared from normal neutrophils and found to contain FAD and cytochrome b in a ratio 2.22:1, suggesting that activation of neutrophils many involve the incorporation of an additional flavin into the membrane. Under anaerobic conditions in the presence of EDTA to act as an electron donor to a flavin, the cytochrome b(-245) of neutrophil membranes was partly (12%) photoreducible, an effect increased to 100% by the addition of FMN. The extent of reduction of cytochrome b in an anaerobic neutrophil homogenate containing NADH increased from 30% to 70% on illumination. We suggest that these results indicate a close association between FAD and cytochrome b(-245) and support a scheme for electron transport thus: [Formula: see text]
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-13475360,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-13654378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-13957122,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-14212420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-16659974,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-16661578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-24176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4145740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4149231,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4275420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4378824,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4382016,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4384043,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-4399354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-454439,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-479180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-6250449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-6261795,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-7115343,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-723935,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-7306076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-7353656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7165731-884324
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0264-6021
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
208
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
759-63
|
pubmed:dateRevised |
2010-9-10
|
pubmed:meshHeading |
pubmed-meshheading:7165731-Cell Membrane,
pubmed-meshheading:7165731-Cytochrome b Group,
pubmed-meshheading:7165731-Electron Transport,
pubmed-meshheading:7165731-Flavin-Adenine Dinucleotide,
pubmed-meshheading:7165731-Granulomatous Disease, Chronic,
pubmed-meshheading:7165731-Humans,
pubmed-meshheading:7165731-Light,
pubmed-meshheading:7165731-Neutrophils,
pubmed-meshheading:7165731-Oxidation-Reduction,
pubmed-meshheading:7165731-Phagocytosis,
pubmed-meshheading:7165731-Spectrometry, Fluorescence
|
pubmed:year |
1982
|
pubmed:articleTitle |
The association of FAD with the cytochrome b-245 of human neutrophils.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|